UBE speeds up Thailand reforms to achieve 2030 vision

UBE Corporation has moved up the implementation of structural reforms at its Thailand base, with downsizing and withdrawal now slated for March 2026, ahead of the previously announced March 2027. This acceleration follows the company's January 28, 2025, announcement regarding its "Vision for 2030," driven by continued sluggish business conditions and stakeholder coordination.

The reforms involve UBE Chemicals (Asia) ceasing production of cyclohexanone, caprolactam, and ammonium sulfate, and reducing nylon polymer lines. Additionally, UBE Fine Chemicals (Asia) will discontinue 1,6-hexanediol and 1,5-pentanediol production. Plans for Japan remain unchanged, with ammonia and related product shutdowns by March 2028 and caprolactam, cyclohexanone, and nylon polymer shutdowns by March 2027.

UBE is currently reviewing the financial impact of this expedited change on its consolidated results for the fiscal year ending March 2026. The company’s consolidated earnings forecast for March 2026 expects net sales of JPY 490,000 million and a profit of JPY 27,500 million attributed to owners of parent, compared to JPY 486,802 million net sales and a loss of JPY (4,816) million in March 2025.